167 related articles for article (PubMed ID: 38388710)
21. Circular RNA-UBE2D2 accelerates the proliferation and metastasis of non-small cell lung cancer cells via modulating microRNA-376a-3p/Eukaryotic Translation Initiation Factor 4γ2 axis.
Tong J; Lu J; Mao X; Zhu Z; Wang Y; Lou M; Zhang K
Bioengineered; 2022 Mar; 13(3):5942-5953. PubMed ID: 35196197
[TBL] [Abstract][Full Text] [Related]
22. Prognostic and clinicopathological significance of TMEFF2, SMOC-2, and SOX17 expression in endometrial carcinoma.
Alabiad MA; Harb OA; Hefzi N; Ahmed RZ; Osman G; Shalaby AM; Alnemr AA; Saraya YS
Exp Mol Pathol; 2021 Oct; 122():104670. PubMed ID: 34339705
[TBL] [Abstract][Full Text] [Related]
23. Paralogous translation factors target distinct mRNAs to differentially regulate tolerance to oxidative stress in yeast.
Cunningham J; Sfakianos AP; Kritsiligkou P; Kershaw CJ; Whitmarsh AJ; Hubbard SJ; Ashe MP; Grant CM
Nucleic Acids Res; 2023 Sep; 51(16):8820-8835. PubMed ID: 37449412
[TBL] [Abstract][Full Text] [Related]
24. LncRNA SDHAP1 confers paclitaxel resistance of ovarian cancer by regulating EIF4G2 expression via miR-4465.
Zhao H; Wang A; Zhang Z
J Biochem; 2020 Aug; 168(2):171-181. PubMed ID: 32211849
[TBL] [Abstract][Full Text] [Related]
25. Intra-axonal synthesis of eukaryotic translation initiation factors regulates local protein synthesis and axon growth in rat sympathetic neurons.
Kar AN; MacGibeny MA; Gervasi NM; Gioio AE; Kaplan BB
J Neurosci; 2013 Apr; 33(17):7165-74. PubMed ID: 23616526
[TBL] [Abstract][Full Text] [Related]
26. Silencing of UCA1, a poor prognostic factor, inhibited the migration of endometrial cancer cell.
Lu L; Shen Y; Tseng KF; Liu W; Duan H; Meng W
Cancer Biomark; 2016 Jun; 17(2):171-7. PubMed ID: 27540975
[TBL] [Abstract][Full Text] [Related]
27. miR-139-5p controls translation in myeloid leukemia through EIF4G2.
Emmrich S; Engeland F; El-Khatib M; Henke K; Obulkasim A; Schöning J; Katsman-Kuipers JE; Michel Zwaan C; Pich A; Stary J; Baruchel A; de Haas V; Reinhardt D; Fornerod M; van den Heuvel-Eibrink MM; Klusmann JH
Oncogene; 2016 Apr; 35(14):1822-31. PubMed ID: 26165837
[TBL] [Abstract][Full Text] [Related]
28. Kinome Profiling of Primary Endometrial Tumors Using Multiplexed Inhibitor Beads and Mass Spectrometry Identifies SRPK1 as Candidate Therapeutic Target.
Kurimchak AM; Kumar V; Herrera-Montávez C; Johnson KJ; Srivastava N; Davarajan K; Peri S; Cai KQ; Mantia-Smaldone GM; Duncan JS
Mol Cell Proteomics; 2020 Dec; 19(12):2068-2090. PubMed ID: 32994315
[TBL] [Abstract][Full Text] [Related]
29. Aneuploidy related transcriptional changes in endometrial cancer link low expression of chromosome 15q genes to poor survival.
Mauland KK; Wik E; Hoivik EA; Kusonmano K; Halle MK; Berg A; Haugland HK; Øyan AM; Kalland KH; Stefansson IM; Akslen LA; Krakstad C; Trovik J; Werner HM; Salvesen HB
Oncotarget; 2017 Feb; 8(6):9696-9707. PubMed ID: 28039471
[TBL] [Abstract][Full Text] [Related]
30. A role for kinesin-1 subunits KIF5B/KLC1 in regulating epithelial mesenchymal plasticity in breast tumorigenesis.
Moamer A; Hachim IY; Binothman N; Wang N; Lebrun JJ; Ali S
EBioMedicine; 2019 Jul; 45():92-107. PubMed ID: 31204277
[TBL] [Abstract][Full Text] [Related]
31. LINC01579 promotes cell proliferation by acting as a ceRNA of miR-139-5p to upregulate EIF4G2 expression in glioblastoma.
Chai Y; Xie M
J Cell Physiol; 2019 Dec; 234(12):23658-23666. PubMed ID: 31187495
[TBL] [Abstract][Full Text] [Related]
32. Interactome of the inhibitory isoform of the nuclear transporter Importin 13.
Fatima S; Wagstaff KM; Lieu KG; Davies RG; Tanaka SS; Yamaguchi YL; Loveland KL; Tam PP; Jans DA
Biochim Biophys Acta Mol Cell Res; 2017 Mar; 1864(3):546-561. PubMed ID: 27993670
[TBL] [Abstract][Full Text] [Related]
33. The transcripts of SFRP1,CEP63 and EIF4G2 genes are frequently downregulated in transitional cell carcinomas of the bladder.
Buim ME; Soares FA; Sarkis AS; Nagai MA
Oncology; 2005; 69(6):445-54. PubMed ID: 16410684
[TBL] [Abstract][Full Text] [Related]
34. MiR-29a-5p inhibits proliferation and invasion and induces apoptosis in endometrial carcinoma via targeting TPX2.
Jiang T; Sui D; You D; Yao S; Zhang L; Wang Y; Zhao J; Zhang Y
Cell Cycle; 2018; 17(10):1268-1278. PubMed ID: 29888640
[TBL] [Abstract][Full Text] [Related]
35. ERα is an RNA-binding protein sustaining tumor cell survival and drug resistance.
Xu Y; Huangyang P; Wang Y; Xue L; Devericks E; Nguyen HG; Yu X; Oses-Prieto JA; Burlingame AL; Miglani S; Goodarzi H; Ruggero D
Cell; 2021 Sep; 184(20):5215-5229.e17. PubMed ID: 34559986
[TBL] [Abstract][Full Text] [Related]
36. In-depth quantitative proteomics analysis revealed C1GALT1 depletion in ECC-1 cells mimics an aggressive endometrial cancer phenotype observed in cancer patients with low C1GALT1 expression.
Montero-Calle A; López-Janeiro Á; Mendes ML; Perez-Hernandez D; Echevarría I; Ruz-Caracuel I; Heredia-Soto V; Mendiola M; Hardisson D; Argüeso P; Peláez-García A; Guzman-Aranguez A; Barderas R
Cell Oncol (Dordr); 2023 Jun; 46(3):697-715. PubMed ID: 36745330
[TBL] [Abstract][Full Text] [Related]
37. An in vitro-transcribed circular RNA targets the mitochondrial inner membrane cardiolipin to ablate EIF4G2
Feng Z; Zhang X; Zhou J; Li Q; Chu L; Di G; Xu Z; Chen Q; Wang M; Jiang X; Xia H; Chen X
Nat Cancer; 2024 Jan; 5(1):30-46. PubMed ID: 37845485
[TBL] [Abstract][Full Text] [Related]
38. KIF15 knockdown inhibits the development of endometrial cancer by suppressing epithelial-mesenchymal transition and stemness through Wnt/β-catenin signaling.
Huang J; Sun X; Diao G; Li R; Guo J; Han J
Environ Toxicol; 2023 Aug; 38(8):1824-1834. PubMed ID: 37186152
[TBL] [Abstract][Full Text] [Related]
39. CKMT1A is a novel potential prognostic biomarker in patients with endometrial cancer.
Wang Y; Zhao S; Qin Q; Gao X; Zhang X; Zhang M; Jiang Y; Ji X; Zhu H; Zhao X; Li H
PLoS One; 2022; 17(1):e0262000. PubMed ID: 35077462
[TBL] [Abstract][Full Text] [Related]
40. Defining the extent of cables loss in endometrial cancer subtypes and its effectiveness as an inhibitor of cell proliferation in malignant endometrial cells in vitro and in vivo.
DeBernardo RL; Littell RD; Luo H; Duska LR; Oliva E; Kirley SD; Lynch MP; Zukerberg LR; Rueda BR
Cancer Biol Ther; 2005 Jan; 4(1):103-7. PubMed ID: 15662117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
